检索结果 - Qin, Xiaobing

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    Origin recognition complex 1 regulates phospholipase Cδ1 to inhibit cell proliferation, migration and epithelial-mesenchymal transition in lung adenocarcinoma

    Origin recognition complex 1 regulates phospholipase Cδ1 to inhibit cell proliferation, migration and epithelial-mesenchymal transition in lung adenocarcinoma 由 Jian, Yao, Qiao, Qing, Tang, Juanjuan, Qin, Xiaobing

    出版 2022
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  2. 2
    Comparative analysis of microRNA expression profiles between A549, A549/DDP and their respective exosomes

    Comparative analysis of microRNA expression profiles between A549, A549/DDP and their respective exosomes 由 Qin, Xiaobing, Yu, Shaorong, Xu, Xiaoyue, Shen, Bo, Feng, Jifeng

    出版 2017
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  3. 3
    Akt/mTOR and AMPK signaling pathways are responsible for liver X receptor agonist GW3965-enhanced gefitinib sensitivity in non-small cell lung cancer cell lines

    Akt/mTOR and AMPK signaling pathways are responsible for liver X receptor agonist GW3965-enhanced gefitinib sensitivity in non-small cell lung cancer cell lines 由 Wang, Qingbo, Shen, Bo, Qin, Xiaobing, Liu, Siwen, Feng, Jifeng

    出版 2019
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  4. 4
    DNA damage promotes microtubule dynamics through a DNA-PK-AKT axis for enhanced repair

    DNA damage promotes microtubule dynamics through a DNA-PK-AKT axis for enhanced repair 由 Ma, Shuyun, Rong, Zeming, Liu, Chen, Qin, Xiaobing, Zhang, Xiaoyan, Chen, Qiang

    出版 2021
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  5. 5
    CPEB4 Inhibit Cell Proliferation via Upregulating p21 mRNA Stability in Renal Cell Carcinoma

    CPEB4 Inhibit Cell Proliferation via Upregulating p21 mRNA Stability in Renal Cell Carcinoma 由 Di, Jiehui, Wang, Hui, Zhao, Zhongjun, Zhao, Guang, Qin, Xiaobing, Han, Zhengxiang, Liu, Yong

    出版 2021
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  6. 6
    Exosome-mediated gefitinib resistance in lung cancer HCC827 cells via delivery of miR-21

    Exosome-mediated gefitinib resistance in lung cancer HCC827 cells via delivery of miR-21 由 Jing, Changwen, Cao, Haixia, Qin, Xiaobing, Yu, Shaorong, Wu, Jianzhong, Wang, Zhuo, Ma, Rong, Feng, Jifeng

    出版 2018
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  7. 7
    Cisplatin-resistant lung cancer cell–derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100–5p-dependent manner

    Cisplatin-resistant lung cancer cell–derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100–5p-dependent manner 由 Qin, Xiaobing, Yu, Shaorong, Zhou, Leilei, Shi, Meiqi, Hu, Yong, Xu, Xiaoyue, Shen, Bo, Liu, Siwen, Yan, Dali, Feng, Jifeng

    出版 2017
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  8. 8
    Epithelial-to-mesenchymal transition correlates with gefitinib resistance in NSCLC cells and the liver X receptor ligand GW3965 reverses gefitinib resistance through inhibition of vimentin

    Epithelial-to-mesenchymal transition correlates with gefitinib resistance in NSCLC cells and the liver X receptor ligand GW3965 reverses gefitinib resistance through inhibition of... 由 Hu, Yong, Zang, Jialan, Qin, Xiaobing, Yan, Dali, Cao, Haixia, Zhou, Leilei, Ni, Jie, Yu, Shaorong, Wu, Jianzhong, Feng, Ji-Feng

    出版 2017
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  9. 9
    Liver X receptors agonist GW3965 re-sensitizes gefitinib-resistant human non-small cell lung cancer cell to gefitinib treatment by inhibiting NF-κB in vitro

    Liver X receptors agonist GW3965 re-sensitizes gefitinib-resistant human non-small cell lung cancer cell to gefitinib treatment by inhibiting NF-κB in vitro 由 Hu, Yong, Zang, Jialan, Cao, Haixia, Wu, Ying, Yan, Dali, Qin, Xiaobing, Zhou, Leilei, Fan, Fan, Ni, Jie, Xu, Xiaoyue, Sha, Huanhuan, Liu, Siwen, Yu, Shaorong, Wang, Zhuo, Ma, Rong, Wu, Jianzhong, Feng, Jifeng

    出版 2017
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:

检索工具: